Cannabinoid inhaler and composition therefor

1. A cannabinoid inhaler comprising:

a housing;

a reservoir within the housing containing an inhalable composition comprising a cannabinoid or a pharmaceutically acceptable derivative or salt thereof, and an alcohol;

a composition flow path from the reservoir and out of a composition outlet at an inhaling end of the housing; and

a non-metered breath operated outlet valve for controlling the flow of inhalable composition through the composition flow path,

wherein:

the breath operated inhaler further comprises an air flow path from an inlet spaced from the inhaling end of the inhaler to an air outlet at the inhaling end, the air flow path being configured such that suction on the inhaling end causes flow through the air flow path which causes the breath operated valve to open, the air outlet being positioned adjacent to the composition outlet, such that air from the air outlet impinges on the composition leaving the composition outlet;

there is a respective air flow outlet on either side of the inhalable composition outlet; and

the air flow outlets are directed towards a composition plume emitted, in use, from the inhaler to break up the particle size of the composition plume.

2. An inhaler according to claim 1 , wherein the outlet valve comprises

a flexible diaphragm within the housing and being positioned so as to be influenced by the air flowing through the air flow path;

a valve element movable with the diaphragm and biased by a biasing force into a position in which it closes the composition flow path;

wherein suction on the inhaling end causes a flow through the air flow path providing a pressure differential across the diaphragm thereby lifting the valve element against the biasing force to open the composition flow path; and

wherein the biasing force is arranged to close the composition flow path once the suction ceases.

3. An inhaler according to claim 2 , further comprising a first air flow path partly defined by one side of the diaphragm, a second air flow path partly defined by the opposite side of the diaphragm, each flow path having an opening at the outlet end, wherein the air flow paths are arranged such that suction at the outlet end results in a pressure differential across the diaphragm that moves the diaphragm and hence moves the valve element against the biasing force to open the composition flow path.

4. An inhaler according to claim 1 wherein at least a portion of the flow path is a deformable tube, and the outlet valve is provided by a clamping member which pinches the deformable tube closed when no suction force is applied to the inhaling end to close the composition flow path and releases the tube to open the composition flow path when suction is applied at the inhaling end.

5. An inhaler according to claim 1 further comprising a refill valve in communication with the reservoir via which the reservoir may be refilled.

6. An inhaler according to claim 1 , wherein the reservoir is pressurised.

7. An inhaler according to claim 6 , wherein the inhalable composition further comprises a propellant.

8. An inhaler according to claim 7 , wherein the size of the reservoir, the pressure within the reservoir, and the size of the composition flow path at its narrowest point are arranged so that, when the outlet valve is fully opened, the reservoir will discharge in less than 30 seconds.

9. An inhaler according to claim 1 , configured to eject the inhalable composition therefrom in the form of droplets, at least 99% vol of the droplets having a diameter of less than 10 microns.

10. An inhaler according to claim 1 , wherein the alcohol is a monohydric alcohol and the inhalable composition further comprises one or more of a glycol and a glycol ether.

11. An inhaler according to claim 10 , wherein the ratio of monohydric alcohol to glycol or glycol ether by weight is from 6:1 to 1:1.

12. An inhaler according to claim 1 , wherein the inhalable composition comprises

one or more cannabinoids or pharmaceutically acceptable derivatives or salts thereof;

a propellant;

a monohydric alcohol; and

a glycol and/or glycol ether

in a weight ratio of monohydric alcohol to glycol/glycol ether of from 6:1 to 1:1.

13. The inhaler of claim 1 comprising the inhalable composition of claim 12 .